Eli Lilly and Company announced that after more than 28 years, Philip Johnson, group vice president and treasurer, will retire from the company at the end of February to pursue a new professional opportunity. Johnson’s successor will be named at a future date.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LLY:
- Foghorn Therapeutics says Lilly selects FHD-909 for clinical development
- Eli Lilly price target raised to $865 from $710 at BMO Capital
- Eli Lilly price target raised to $850 from $650 at Truist
- Amgen downgraded to Market Perform from Outperform at Leerink
- Eli Lilly price target raised to $825 from $700 at Wells Fargo